Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
IMMX compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
IMMX
Immix Biopharma, Inc.
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
IMMX
Immix Biopharma, Inc.
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only IMMX
0
None
Shared
0
No disclosed counterparties: IMMX.
Only LLY
29
MCK
McKesson
customer
CAH
Cardinal Health
customer
VEEV
Veeva Systems
supplier
UTHR
United Therapeutics
customer
25 more · LLY chain
›
Role chip = supplier or customer
Source: SEC EDGAR
IMMX
Immix Biopharma, Inc.
Change
7.23
▼
−9.23%
Mkt cap
$570.2M
Revenue
—
Revenue
—
LLY
ELI Lilly & Co
Change
1,380.36
▼
−2.65%
Regular session
Nov 5 '26
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
Regular session
Nov 5 '26
IMMX
Immix Biopharma, Inc.
vs
LLY
ELI Lilly & Co
7.23
▼
−9.23%
Price
1,380.36
▼
−2.65%
$570.2M
Mkt cap
$1.3T
—
Revenue
$24.4B
Q3 FY26
—
Revenue
$65.2B
FY25
Change
Change
IMMX
7.23
▼
−9.23%
vs
LLY
1,380.36
▼
−2.65%
Regular session
Nov 5 '26